Rachel A. Peat

932 total citations
15 papers, 629 citations indexed

About

Rachel A. Peat is a scholar working on Molecular Biology, Immunology and Allergy and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rachel A. Peat has authored 15 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and Allergy and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rachel A. Peat's work include Muscle Physiology and Disorders (8 papers), Cell Adhesion Molecules Research (4 papers) and Cardiomyopathy and Myosin Studies (3 papers). Rachel A. Peat is often cited by papers focused on Muscle Physiology and Disorders (8 papers), Cell Adhesion Molecules Research (4 papers) and Cardiomyopathy and Myosin Studies (3 papers). Rachel A. Peat collaborates with scholars based in Australia, United States and United Kingdom. Rachel A. Peat's co-authors include David G. Little, Paul Williams, Kathryn N. North, Shireen R. Lamandé, Naomi L. Baker, Paul A. Baldock, Rishika A. Pace, Pascale Guicheney, Michelle M. McDonald and Ian Sharpe and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Neurology.

In The Last Decade

Rachel A. Peat

15 papers receiving 619 citations

Peers

Rachel A. Peat

OSM

SURGE

CCM

ONCOL

P. van der Kraan Netherlands

C. Wennberg Sweden

Nuria Lara-Castillo United States

Carole Le Hénaff France

Yougen Xi United States

Aruna Khare United States

Akihiro Kotani Japan

Hajime Inoue Japan

Val Mann United Kingdom

J.G.H. Sterck Netherlands

P. van der Kraan Netherlands

Rachel A. Peat

301 ×1.0

47 ×0.3

OSM

113 ×0.8

SURGE

28 ×0.3

CCM

96 ×1.0

ONCOL

Citations per year, relative to Rachel A. Peat Rachel A. Peat (= 1×) peers P. van der Kraan

Countries citing papers authored by Rachel A. Peat

Since Specialization

Citations

This map shows the geographic impact of Rachel A. Peat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Peat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Peat more than expected).

Fields of papers citing papers by Rachel A. Peat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Peat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Peat. The network helps show where Rachel A. Peat may publish in the future.

Co-authorship network of co-authors of Rachel A. Peat

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Peat. A scholar is included among the top collaborators of Rachel A. Peat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Peat. Rachel A. Peat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Skerrett, Donna, Ravi Krishnan, Rachel A. Peat, et al.. (2024). EFFECTS OF PENTOSAN POLYSULFATE SODIUM ON CLINICAL OUTCOMES AND DISEASE MODIFYING BIOMARKERS IN MODERATE TO SEVERE KNEE OSTEOARTHRITIS. Osteoarthritis and Cartilage. 32. S50–S51. 2 indexed citations

Schoenmakers, Erik, Bradley A. Carlson, Maura Agostini, et al.. (2016). Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis. Journal of Clinical Investigation. 126(3). 992–996. 56 indexed citations

Ferry, Arnaud, Rachid Benchaouir, Pierre Joanne, et al.. (2015). Effect of voluntary physical activity initiated at age 7 months on skeletal hindlimb and cardiac muscle function in mdx mice of both genders. Muscle & Nerve. 52(5). 788–794. 16 indexed citations

Clarke, Nigel F., Svetlana Maugenre, Aurélie Vandebrouck, et al.. (2011). Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE gene. European Journal of Human Genetics. 19(4). 452–457. 40 indexed citations

Bartos, Daniel C., Sabine Duchatelet, Don E. Burgess, et al.. (2010). R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. Heart Rhythm. 8(1). 48–55. 57 indexed citations

Evesson, Frances J., Rachel A. Peat, Angela Lek, et al.. (2010). Reduced Plasma Membrane Expression of Dysferlin Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway. Journal of Biological Chemistry. 285(37). 28529–28539. 38 indexed citations

Zamurs, Laura, Naomi L. Baker, Rachel A. Peat, et al.. (2010). Collagen VI Microfibril Formation Is Abolished by an α2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy. Journal of Biological Chemistry. 285(43). 33567–33576. 17 indexed citations

Peat, Rachel A., Jozef Gécz, Justin R. Fallon, et al.. (2008). Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders. Neuromuscular Disorders. 18(8). 606–609. 3 indexed citations

Pace, Rishika A., Rachel A. Peat, Naomi L. Baker, et al.. (2008). Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity. Annals of Neurology. 64(3). 294–303. 54 indexed citations

10.

Peat, Rachel A., Naomi L. Baker, Kristi Jones, Kathryn N. North, & Shireen R. Lamandé. (2007). Variable penetrance of COL6A1 null mutations: Implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families. Neuromuscular Disorders. 17(7). 547–557. 30 indexed citations

11.

Baker, Naomi L., Matthias Mörgelin, Rishika A. Pace, et al.. (2007). Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Annals of Neurology. 62(4). 390–405. 50 indexed citations

12.

Peat, Rachel A., Janine Smith, Alison G. Compton, et al.. (2007). Diagnosis and etiology of congenital muscular dystrophy. Neurology. 71(5). 312–321. 61 indexed citations

13.

Little, David G., et al.. (2005). Zoledronic acid improves femoral head sphericity in a rat model of perthes disease. Journal of Orthopaedic Research®. 23(4). 862–868. 62 indexed citations

14.

Peat, Rachel A., et al.. (2003). Low-Intensity Ultrasound Stimulation in Distraction Osteogenesis in Rabbits. Clinical Orthopaedics and Related Research. 417(417). 303–312. 28 indexed citations

15.

Little, David G., et al.. (2003). Zoledronic Acid Treatment Results in Retention of Femoral Head Structure After Traumatic Osteonecrosis in Young Wistar Rats. Journal of Bone and Mineral Research. 18(11). 2016–2022. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact